// On this page
Update, 11 June 2026: four weeks after this test, Cortex Digests vanished from my account entirely, the mobile app included. The update at the end has the details. The review stands as the record of what the feature did while UK accounts had it.
Cortex Digests works on the Robinhood UK mobile app, on well-known names, and nowhere else I could find. On the website, same account, same stocks, same day, it doesn’t exist: not on META, not on the portfolio dashboard, not in the Legend chart workspace. If you research from a laptop, the AI feature Robinhood announced in August 2025 is not part of your product.
That’s the Robinhood Cortex Digests review in two sentences. The rest is the evidence: a logged-in session on my own UK ISA, screenshots timestamped, the Digest’s numbers checked against Meta’s reported results, plus the three things still missing even where the feature works.
The marketing called Cortex Digests an AI feature that summarises news and technicals in plain English for “Robinhood customers.” I went looking on the website first: META, BMNR, the dashboard, the Legend chart workspace. Nothing. Then I opened the mobile app and went to META. There it was. Same account, same stock, same day, two different products, and the same company sells both of them.
A feature you've announced is not the same as a feature your users can see.
What Cortex Digests showed on the web
The dixon.ai test was a Playwright session against my logged-in UK ISA account, 1440×900 viewport, four places in sequence:
- META detail page: stock rendered at $610.05, full layout present (chart, About, Key statistics, Related lists, News, Trading Trends, Analyst ratings). No Digest panel. Searched the page text for digest or cortex. Zero matches.
- BMNR detail page: stock at $19.81, same layout shape. No Digest panel. Same page-text search: nothing.
- Portfolio dashboard: loaded the classic UK home view. No Digest panel. Same: nothing.
- Robinhood Legend: the chart workspace. No Digest panel. Same: nothing.
Robinhood’s August 2025 launch announcement said Cortex Digests was “free to all UK customers at launch” and noted it was “not available for every company or security”. Coverage is gated by page-view metrics, per the methodology page. META is one of the most-viewed names on the platform. If Cortex was live for UK web accounts, this is where it would appear.
What the mobile app actually shows
Then I opened the mobile app on the same account and tapped through to META. The Digest panel sits inline on the detail page, above the “About Meta Platforms” section, labelled clearly with a Digests → chevron. The headline read: “Meta Platforms down 0.68% from Friday’s close amid strong Q1 earnings and rising debt concerns.” Below it: “Updated 7m ago · AI-powered, not advice.”
Tapping the chevron opens the full reading view. It is structured: two named sub-sections, plain English, with verifiable numbers. The first sub-section, “Strong Q1 earnings”, reads:
Meta reported Q1 2026 results on April 29, showing 33% revenue growth to $56.31 billion and a 62% rise in diluted EPS to $10.44. Advertising demand and AI infrastructure investments drove strong operating income growth despite heavy capital spending. The Family of Apps segment led revenue gains, while Reality Labs remained a loss-making unit. No updated full-year guidance was provided.
The second, “Senior notes offering”, picks up the May 4 $25bn debt issuance: six maturities, coupons from 4.55% to 6.45%, the implications for interest expense.
The numbers track. $56.31bn is what Meta reported. 33% year-on-year growth is correct. $10.44 diluted EPS is correct. The $25bn senior notes offering on May 4 happened. The Digest does what its disclaimer says it does: passive news synthesis with sources behind it, presented as text not as a recommendation.
One thing it didn’t flag, though, is worth holding next to that “the numbers track” verdict. That $10.44 earnings-per-share figure, the profit Meta made for each share you own, included an $8.03bn one-off tax benefit. Strip that out and the comparable figure is nearer $7.31, which makes the year-on-year jump closer to 14% than the headline 62%. Both numbers are real; the Digest quoted the one that flatters. It read the company’s own release accurately and inherited the company’s own framing wholesale. That’s the quiet limit of a summary tool: it’s only ever as sceptical as the document it’s summarising, and a results announcement is not a sceptical document.
It does this well enough that, on the right name, it would save you opening three tabs. That’s the use case Robinhood marketed and that’s what it does: a quick mobile-app news summary on big, well-known companies.
What’s missing, even on mobile
The wins above are narrow. The same screenshots are the evidence for what isn’t there.
There’s no options data. The methodology page is explicit about this: options and futures are out of scope. For anyone running a covered-call income strategy (selling the right to buy your shares at a set price, in exchange for a cash premium up front, which is the central use case for an active Robinhood account, mine included) the AI feature in the platform says nothing about the contract you’re trading. Not the strike price, not implied volatility (how big a move the market is pricing in), not whether the premium is worth taking. That isn’t a bug. It is the product boundary. But it does mean the AI feature attached to your broker has nothing to say about the thing you actually opened the broker to do.
There’s no portfolio-level Digest visible on this account. Portfolio Digests, the portfolio-level version, haven’t been announced for UK accounts. The August 2025 UK launch described Asset-level (single-stock) Digests only; Portfolio Digests have been rolling out to US Robinhood Gold subscribers in early 2026. The mobile test was limited to the META detail page; a portfolio-level mobile view wasn’t captured.
And the coverage wall on less-tracked names is still open. The web test recorded the absence on the less-tracked stock I trade (BMNR); the mobile version hasn’t been tested. The methodology gates Digests by page views. If that rule also runs on mobile, the verdict holds on both web and app. If it doesn’t, the gap is narrower than the methodology page reads.
I'd rather flag the unverified dimension honestly than write a verdict around evidence I don't have.
One provenance note worth carrying. The methodology page lists “aggregated Robinhood customer trading data” as one input to the Digest. That isn’t a conspiracy. Robinhood is up-front about it on the page. It is a thing to hold in mind. The AI summary you read on your broker is partly informed by what other Robinhood customers are doing on the same stock. Sometimes that’s a useful signal; sometimes it’s the noise of retail sentiment lagging the move. It is not the same provenance as an independent research tool, and it shouldn’t be read as one.
Field Report
What worked: On a well-known company like Meta, the mobile Digest does what it claims: numbers that match the reported results, two structured sub-sections, and a footer that calls itself AI-powered rather than advice. It quoted the company accurately, including the flattering headline EPS, without the caveat a sceptical reader would want.
What didn’t: Missing from every place tested on the Robinhood UK web interface. No options coverage. No portfolio-level Digest visible on this UK ISA account.
Bottom line: Was useful as a quick mobile news summary on well-known names like Meta, until it vanished from the app in June 2026 (see the update below). While it existed: missing on the website, no options coverage, a faster way to read the headlines, not research.
If you bank on the AI feature in the Robinhood UK announcement and you’re working from your laptop, the mobile app is where it lives. It is useful in one narrow way: a quick way to scan the news on well-known companies, the kind of name where the news is already everywhere and the model’s job is to thin it down. It is no use for any decision involving options. It reads as something to glance at above your own research, not in place of it.
A product is whatever the user can see. On the Robinhood UK website right now, this product is invisible. That gap will close. Robinhood will either bring Cortex to the web or quietly stop marketing the feature as available to UK customers at large. But the timestamp on these screenshots shows what was true today.
Five questions to ask before depending on any broker's built-in AI feature, derived from what this review found missing.
- Does it cover options? Most broker AI tools, including Cortex Digests, explicitly exclude options and futures, which means the AI has nothing to say about the contract you may have actually opened the platform to trade.
- Does it work where you work? Cortex Digests was invisible on the Robinhood web interface and only appeared in the mobile app. If your research happens on a laptop, check before assuming the feature is available to you.
- Does it cover the stocks you actually hold? Coverage is gated by popularity. The test here found nothing on a less-tracked name (BMNR), while Meta had a full Digest. Your smaller holdings may not qualify.
- Is it available in your country and account tier? Cortex Digests launched free for UK users in 2025 and by June 2026 had been folded into a paid US tier UK accounts cannot buy. A feature your broker announced is not necessarily one you still have.
- Does it tell you what the numbers mean, or just what they are? The Meta Digest quoted the headline earnings figure accurately, including the one that flattered. It did not flag that a large one-off tax benefit inflated the year-on-year jump. A summary tool inherits the framing of whatever document it summarises.
Update: gone from mobile too (11 June 2026)
The May verdict above was “missing on web, working on mobile.” As of this evening, the second half of that sentence is dead. I checked NVDA, META and MSFT on the mobile app, including the same META detail page where the Digest panel sat in May, and the panels are gone. The web version never had them; now the app doesn’t either. On my UK account, Cortex Digests no longer exists.
I can’t find an announcement. What I can find is that Robinhood’s US support page now describes Digests as a benefit of Robinhood Gold, the $5-a-month subscription tier that doesn’t exist in the UK. My reading, offered as a reading and not a fact: the feature that launched “free to all UK customers” in August 2025 has been folded into a paid tier UK customers can’t buy. If Robinhood says otherwise, I’ll update this again.
The original close of this review said the web-mobile gap would resolve one of two ways: Robinhood brings Cortex to the web, or quietly stops marketing it to UK customers. I missed the third option: remove it from the app as well and say nothing. A product is whatever the user can see, and on this account that is now nothing.
The review above stands as the record of what Cortex Digests did in the ten months UK accounts had it, including a line-by-line accuracy check of a META Digest. It’s history now, not a buying guide. And if part of your research routine ever comes to depend on an AI feature inside your broker, this page is the case for keeping the manual version of that step warm.
Can you still get Cortex Digests? (June 2026)
Here is the part I couldn’t square. The feature has been missing from my UK account since June, yet Robinhood’s own UK page for it still says Digests is “here” and free to all UK customers. The US support page, meanwhile, now files the same feature under Robinhood Gold, the five-dollar-a-month tier that carries the rest of Cortex, including Portfolio Digests and the newer Cortex Assistant. Gold isn’t sold in the UK.
So the answer depends on which source you trust: the UK marketing page says yes and free; the US route says yes, but only inside a subscription UK accounts can’t buy; my actual account says no. The only one of those three I can open is the last. A feature that is advertised but not present is not a feature you have, however generously the page describes it.
If you’re weighing whether to rely on it, the honest steer is don’t, for now. There’s no paid UK route to switch it back on, and the free one the page promises wasn’t there when I looked. What’s worth using in its place doesn’t depend on any one broker: the free AI tools I rate for stock research run on a laptop and don’t vanish when a subscription tier changes. If that changes, this page changes with it.
Ben tests how far you can trust the main AI assistants, and publishes exactly where they get things wrong. Every post here is a first-hand test with the receipts, including the times a tool simply wasn’t worth the trust. About Ben →
The site runs AI on real investing decisions. Start with the Prompt Stack for the four-stage framework, free and ungated, or the Bluff Filter for the paste-ready version with a real before and after.